Showing 1 - 23
of 23 results

News Center

Syntermed appointed by Lantheus as distributor of PYLARIFY AI™

March 31, 2022Syntermed announces its appointment by Lantheus Holdings, Inc. as the first U.S. distributor of PYLARIFY AI™, the first and only FDA-cleared artificial intelligence platform developed to assist standardized quantification of PSMA PET/CT scans.

ASNC Announces ImageGuide Registry Certification of Emory Toolbox

April 03, 2016Practitioners using Emory Toolbox v.4 will be able to seamlessly transmit data in real-time to the ImageGuide Registry in lieu of manual web-based data entry.

Syntermed, Inc. announces support for the ASNC ImageGuide Data Registry

September 18, 2015Syntermed, Inc will be at American Society of Nuclear Cardiology 2015 annual meeting (Sept. 17-20, Booth 206) demonstrating Emory Toolbox 4.0 and Syntermed IDS™ and SmartReport, as well as assisting ASNC members with technical questions regarding the impending integration to the ASNC ImageGuide™ Data Registry. Syntermed/Emory Toolbox is an official vendor for the registry.

Syntermed announces availability of transaxial reorientation as part of Emory Toolbox 4.0

June 05, 2015Syntermed, Inc. announces two significant software updates to Emory Toolbox v4: Transaxial reorientation and Post-Facto reorientation. Syntermed President Ken Van Train remarks, Emory Toolbox v4 is built on a .NET architecture, enabling Syntermed software developers to bring a strong pipeline of new features to the market more quickly.

Syntermed Announces Expanded Availability of Emory Toolbox 4.0 and NeuroQ at RSNA

December 01, 2014Syntermed, Inc. announces that Emory Toolbox 4.0 and NeuroQ 3.6 will be available on the Philips Healthcare IntelliSpace Portal 7 platform. NeuroQ™ 3.6 brain imaging analysis assists in the differential diagnosis of dementias and tracks the progress of these diseases; Emory Toolbox 4.0, includes new levels of clinical decision support for cardiac imaging.

Syntermed's Emory Toolbox and NeuroQ have Expanding Global Footprint in Asia

November 30, 2014Emory Toolbox 4.0 with Syntermed IDS™ and SmartReport™ now offer physicians an arsenal of smarter, diagnostic heart imaging tools. The versatility and adaptability of Emory Toolbox and NeuroQ is gaining momentum in various Asian markets including Taiwan, China and Korea.

Syntermed's NeuroQ™ 3.7 for SPECT Brain Imaging Announced at RSNA

November 29, 2014In 2013 Syntermed, Inc. received 510K clearance from the Food and Drug Administration for NeuroQ™ 3.6, software used in nuclear medicine clinics for PET-FDG brain scans plus an additional clearance for its amyloid brain uptake imaging application. As a work in progress, that 510K clearance extends to Syntermed’s newest nuclear medicine software, NeuroQ 3.7 for SPECT brain imaging quantification.

Syntermed Announces New Software Applications for Emory Toolbox 4.0

October 01, 2014At the recent ASNC annual meeting, Syntermed, Inc. unveiled the Emory Toolbox 4.0's newest diagnostic capabilities: FlowTool™ for cardiac PET studies, SyncTool™ with AdreView Tools for the quantitative evaluation of heart failure, and post factor reorientation for either SPECT or PET tomogram misalignment.

Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters

September 20, 2014Syntermed, Inc. showcases new diagnostic software applications for its Emory Toolbox 4.0 at the American Nuclear Cardiology Society 2014 annual meeting including two scientific posters presented by David Cooke. Emory Toolbox 4.0 with Syntermed IDS™ is a smarter solution for achieving better levels of clinical decision support,

Syntermed and GE Healthcare Showcase Xeleris With AdreView Tools at SNMMI 2014

June 05, 2014GE Healthcare and Syntermed, Inc. will be exhibitors at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. AdreView Tools* will be featured by both companies as an advanced diagnostic tool to quantify and display SPECT 123I-mIBG) data sets, a new medical advance for diagnosis of heart failure.

Syntermed's NeuroQ™ 3.7 for SPECT Brain Imaging to Be Previewed at SNMMI

May 31, 2014In 2013 Syntermed, Inc. received 510K clearance from the Food and Drug Administration for NeuroQ™ 3.6, software used in nuclear medicine clinics for PET-FDG brain scans plus an additional clearance for the its amyloid brain uptake imaging application. As a work in progress, that 510K clearance extends to Syntermed’s newest nuclear medicine software, NeuroQ 3.7 for SPECT brain imaging quantification.

Syntermed’s Emory Toolbox™ 4.0 and Advances in Heart Failure Diagnosis

April 30, 2014This month, Syntermed, Inc. launched its new Emory Toolbox 4.0 software through all channels, OEMS, VARS and direct. Emory Toolbox 4.0 is currently the only system .NET architecture for evaluating two different avenues of heart failure and quantitatively providing a more accurate diagnosis of the disease.

Syntermed’s SyncTool™ Software to Be Used in International Heart Failure Clinical Trial

November 21, 2013Syntermed, Inc. announces their SyncTool nuclear cardiology imaging software is being used in the VISION-CRT clinical trial with sites in nine countries. SyncTool is a phase analysis software tool that analyzes the benefits of cardiac resynchronization therapy in heart failure patients.

Syntermed’s Video Demo, Emory (Cardiac) Toolbox™ 4.0 and SmartReport™: Software with a Brain

October 22, 2013Emory Toolbox 4.0 is the first 510K accepted by FDA for (cardiac) image decision support; now with "smarts" to allow interpretation of SPECT and PET myocardial perfusion studies. As reported at ASNC, the outcomes from the 1000-patient Emory University study showed Emory Toolbox 4.0 and SmartReport has a sensitivity, specificity and accuracy that is comparable to that of the nuclear cardiology expert.

Syntermed Receives FDA Clearance for AdreView Tools™

October 01, 2013Syntermed's software AdreView Tools, a new application for Emory Cardiac Toolbox, is now FDA cleared and has an expanded indication: first, for the quantitative analysis and display of SPECT AdreViewTM (123I-mIBG) data sets used for evaluation of patients with congestive heart failure, and second, AdreView Tool can be used for the quantitative analysis of SPECT studies.

Syntermed Media Advisory: Emory Toolbox 4.0 and SmartReport Showcased at ASNC, September 26-29, Booth 516

September 20, 2013Syntermed, Inc, based in Atlanta, GA, will be an exhibitor at this year's American Society of Nuclear Cardiology annual meeting, booth 516. Syntermed has a new medical imaging software product called SmartReport, and along with the recently FDA cleared Emory Toolbox 4.0, these products are steamlining data-driven technology in the nuclear cardiology labs to improve workflow, simplify EMR integration, and generate faster SPECT myocardial perfusion imaging reports all on a cloud-based, remote access system.

International Atomic Energy Agency licenses Syntermed’s Emory Toolbox for 7 Latin American Countries to Diagnosis Heart Failure Due to Chagas Disease

September 09, 2013Nuclear cardiology labs in Latin America will have access to Syntermed's new Emory Toolbox 4.0 software for the assessment of their heart failure patients as it relates to Chagas disease. The licenses will be provided through a regional cooperation project of the International Atomic Energy Agency.

Syntermed's NeuroQ 3.6(TM) is FDA Cleared with 510K Indication for the Analysis of Amyloid Uptake in Brain

May 29, 2013Syntermed, Inc received 510K clearance from the Food and Drug Administration (FDA) for NeuroQ(TM) version 3.6, a software used in nuclear medicine clinics for PET brain scans. NeuroQ is now cleared for the analysis of amyloid uptake levels in various regions of the brain.

Syntermed Awarded 510(k) Clearance for Novel Cardiac Imaging Decision Support System – Emory Toolbox™ 4.0

May 20, 2013Syntermed to launch Emory Toolbox 4.0 with the new SmartReport powered by Syntermed IDS at the June meeting of the Society of Nuclear Medicine and Molecular Imaging. Emory Toolbox™ 4.0 is the result of an award (1 R42 HL106818-01) from the National Heart, Lung and Blood Institute titled “Novel WEB Decision Support System for cardiac image interpretation and reporting.”

Syntermed Launches NeuroQ 3.5 - Nuclear Medicine Diagnostic Program at Alzheimer’s Association 2010 International Conference

July 12, 2010More than 40 percent of patients diagnosed with early dementia, were found not to have Alzheimer’s disease on autopsy. Other forms of dementia and conditions that can cause memory problems go undiagnosed and untreated. Syntermed's NeuroQ software program increases accuracy of FDG-PET brain imaging for improved diagnosis of dementia and AD. Syntermed, Inc. is also collaborating with Avid Radiopharmaceuticals to quantify Amyloid uptake for Alzheimer’s diagnosis. Secure remote access of PET Scans for Clinical Trials is now possible with Syntermed Live™.

Dr. Silverman comments on July 11 AV-45 clinical presentation at the International Conference on Alzheimer’s Disease (ICAD)

July 11, 2010Daniel Silverman, MD, PhD, Director, UCLA Geffen School of Medicine, Brain Imaging Clinic comments on newest advances in diagnosing Alzheimer’s disease (AD) based on the July 11 AV-45 clinical presentation at ICAD. His team is presenting results of their current research using FDG-PET brain imaging and NeuroQ. The poster titled “Clinical and quantitative fluorodeoxyglucose positron emission tomography in pre- and symptomatic persons inheriting familial Alzheimer's disease mutations," will be presented Monday, Jul 12, at 11:30 AM - 1:00 PM (HST). As the head of the Neuronuclear Imaging Section at the David Geffen School of Medicine at UCLA, Dr. Silverman is an internationally known researcher, specializing in nuclear medicine imaging studies for the improved diagnosis and treatment of many types of dementia, including AD.

GE Healthcare Demonstrates Sync Tool™ on its Xeleris 2 Workstation -- Nuclear Cardiac Imaging Software Licensed from Syntermed

September 12, 2008SyncTool software helps to predict which heart failure patients will benefit from cardiac resynchronization therapy (CRT). Syntermed also unveils ReconTools™ at the American Society of Nuclear Cardiology, Sept. 10-14, Boston, MA. Emory University announced it is exclusively licensing Emory Reconstruction Toolbox (ERTb) to Syntermed and the company will market ERTb software as ReconTools™. ReconTools provide reconstructed data sets that can be analyzed by many quantitative platforms including Emory Cardiac Toolbox™ (ECTb), providing an integrated, complete software solution for myocardial perfusion SPECT imaging.

Remote Readers, a New Group of Nuclear Cardiologists, Use Syntermed Live™ to Improve Diagnostic Value of Nuclear Heart Images

September 11, 2008Syntermed, Inc., an Atlanta-based nuclear medicine imaging and informatics software company will demonstrate several new cardiac imaging software programs at the American Society of Nuclear Cardiologists, meeting in Boston through Sunday. Syntermed Live is one of the featured products along with Emory Cardiac Toolbox, SyncTool and ReconTool. ..."Nuclear cardiologists are utilizing the Syntermed Live™ system to easily access secure, high-resolution heart images and diagnostic information. The trend towards virtual access and remote reading is more than a convenience for nuclear cardiologists. They can now retrieve archived files for comparison studies and communicate quickly with colleagues..."

Showing 1 - 23
of 23 results

News Center